Manage Account - Modern Medicine
Drug safety: Isotretinoin makers to comply with new FDA monitoring plan
Publish date: May 1, 2008
By: Nancy A. Melville

Manufacturers of isotretinoin are awaiting more information to determine whether iPLEDGE — the mandatory federal drug registry already in place — will meet the Food and Drug Administration's new safety plan requirements.

The journal page you requested is now available only to registered Modern Medicine members.

Register Here

Registration is Free!
(and Takes Less than a Minute)

RegisterUS Physicians, click here
for express registration.

RegisterHealthcare Professionals,
click here

Modern Medicine Offers:
» Practice Management Advice
» CME / ICD-9 Coding / Formulary
» Patient Education Handouts
» Peer-reviewed Articles
» Conference Coverage, Email Alerts & More

Click Here to Watch the Tour

Already Registered?

Login Now

Login Email:Password:
Forgot Your Password?Remember me.
Source: Dermatology Times, 5/1/2008
Click here